Clinical Trial Update: Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms [Phase 1]

View source ↗

Summary

Phase 1 trial update for PF-00562271 in head and neck cancer, prostate cancer, and pancreatic cancer; the study is completed and results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Pancreatic Cancer
• Prostate Cancer

Drugs mentioned

• PF-00562271 (PF-00562271)

Snippet

Sponsor: Verastem, Inc. | Conditions: Head and Neck Neoplasm, Prostatic Neoplasm | Phase 1 | Status: COMPLETED | Results posted: 2012-06-14